Search Results - sommer+zimmerman

1 Results Sort By:
Small Molecule Potentiators for Treatment of Central Nervous System Disorders
Application Series of compounds for selectively potentiating N-methyl-D-aspartate (NMDA) receptor subunit NR2C for treating central nervous system impairment. Key Benefits Selectivity for NR2C may reduce possibility of adverse side effects. Market Summary N-methyl-D-aspartate (NMDA) receptors are widely dispersed in the central nervous system...
Published: 7/30/2024   |   Inventor(s): Stephen Traynelis, Praseeda Mullasseril, Ethel Garnier-Amblard, Dennis Liotta, Sommer Zimmerman
Keywords(s): Neuroscience/Pain, Small Molecule
Category(s): TechPub Algolia > Therapeutics, TechPub Algolia > Drug Discovery